Cite

MLA Citation

    Yajnavalka Banerjee et al.. “Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?.” Atherosclerosis, vol. 248, 2016, pp. 62–75. http://access.bl.uk/ark:/81055/vdc_100031532154.0x000035
  
Back to record